These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 18830031)
21. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E; N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000 [TBL] [Abstract][Full Text] [Related]
22. Early and late outcomes after primary percutaneous coronary intervention by radial or femoral approach in patients presenting in acute ST-elevation myocardial infarction and cardiogenic shock. Bernat I; Abdelaal E; Plourde G; Bataille Y; Cech J; Pesek J; Koza J; Jirous S; Machaalany J; Déry JP; Costerousse O; Rokyta R; Bertrand OF Am Heart J; 2013 Mar; 165(3):338-43. PubMed ID: 23453102 [TBL] [Abstract][Full Text] [Related]
23. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction complicated with cardiogenic shock. Gao R; Yao K; Chen J; Yang Y; Qiao S; Xu Y; Chen Z Chin Med J (Engl); 1996 Aug; 109(8):583-7. PubMed ID: 9206056 [TBL] [Abstract][Full Text] [Related]
24. Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock--a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry. Jeger RV; Tseng CH; Hochman JS; Bates ER Am Heart J; 2006 Oct; 152(4):686-92. PubMed ID: 16996836 [TBL] [Abstract][Full Text] [Related]
25. The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators. Hussain F; Philipp RK; Ducas RA; Elliott J; Džavík V; Jassal DS; Tam JW; Roberts D; Garber PJ; Ducas J Catheter Cardiovasc Interv; 2011 Oct; 78(4):540-8. PubMed ID: 21547996 [TBL] [Abstract][Full Text] [Related]
26. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. French JK; Feldman HA; Assmann SF; Sanborn T; Palmeri ST; Miller D; Boland J; Buller CE; Steingart R; Sleeper LA; Hochman JS; Am Heart J; 2003 Nov; 146(5):804-10. PubMed ID: 14597928 [TBL] [Abstract][Full Text] [Related]
27. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients. Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036 [TBL] [Abstract][Full Text] [Related]
28. Successful combined use of Impella Recover 2.5 device and intra-aortic balloon pump support in cardiogenic shock from acute myocardial infarction. Wiktor DM; Sawlani N; Kanthi Y; Sipahi I; Fang JC; Blitz A ASAIO J; 2010; 56(6):519-21. PubMed ID: 20938341 [TBL] [Abstract][Full Text] [Related]
29. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Zeymer U; Vogt A; Zahn R; Weber MA; Tebbe U; Gottwik M; Bonzel T; Senges J; Neuhaus KL; Eur Heart J; 2004 Feb; 25(4):322-8. PubMed ID: 14984921 [TBL] [Abstract][Full Text] [Related]
30. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group. Second Chinese Cardiac Study (CCS-2) Collaborative Group J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013 [TBL] [Abstract][Full Text] [Related]
31. Use of c7E3 Fab in conjunction with primary coronary stenting for acute myocardial infarctions complicated by cardiogenic shock. Schultz RD; Heuser RR; Hatler C; Frey D Cathet Cardiovasc Diagn; 1996 Oct; 39(2):143-8. PubMed ID: 8922314 [TBL] [Abstract][Full Text] [Related]
32. Predictors of mortality at 30 days in high-risk patients treated with direct or rescue stenting for acute myocardial infarction: a single center experience. La Vecchia L; Martini M; Sartori M; Vincenzi P; Cischele L; Righetti T; Ometto R; Fontanelli A J Invasive Cardiol; 2001 Oct; 13(10):689-93. PubMed ID: 11581511 [TBL] [Abstract][Full Text] [Related]
33. Dual thienopyridine low-response to clopidogrel and prasugrel in a patient with STEMI, cardiogenic shock and early stent thrombosis is overcome by ticagrelor. Orban M; Riegger J; Joner M; Tada T; Okrojek R; Hausleiter J; Kastrati A; Massberg S; Sibbing D Platelets; 2012; 23(5):395-8. PubMed ID: 22671583 [TBL] [Abstract][Full Text] [Related]
34. Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy. Smit JJ; van Werkum JW; ten Berg J; Slingerland R; Ottervanger JP; Heestermans T; Dill T; Hamm C; van 't Hof AW; Heart; 2010 Nov; 96(22):1815-20. PubMed ID: 20889993 [TBL] [Abstract][Full Text] [Related]
35. Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock. Tsao NW; Shih CM; Yeh JS; Kao YT; Hsieh MH; Ou KL; Chen JW; Shyu KG; Weng ZC; Chang NC; Lin FY; Huang CY J Crit Care; 2012 Oct; 27(5):530.e1-11. PubMed ID: 22591567 [TBL] [Abstract][Full Text] [Related]
36. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience. Engström AE; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; de Jong M; Lagrand WK; van der Sloot JA; Tijssen JG; de Winter RJ; de Mol BA; Piek JJ; Henriques JP Crit Care Med; 2011 Sep; 39(9):2072-9. PubMed ID: 21602670 [TBL] [Abstract][Full Text] [Related]
37. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. Tayara W; Starling RC; Yamani MH; Wazni O; Jubran F; Smedira N J Heart Lung Transplant; 2006 May; 25(5):504-9. PubMed ID: 16678027 [TBL] [Abstract][Full Text] [Related]
38. Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis? Drakos SG; Anastasiou-Nana MI; Terrovitis JV; Tsagalou EP; Kanakakis J; Ntalianis A; Lazaris N; Maroulidis G; Venetsanakos J; Bonios M; Nanas JN Coron Artery Dis; 2008 Nov; 19(7):521-6. PubMed ID: 18923249 [TBL] [Abstract][Full Text] [Related]
39. Acute myocardial infarction complicated by cardiogenic shock. In-hospital and mid-term results of invasive treatment in the National Institute of Cardiology, Warsaw-Anin. Karcz M; Bekta P; Kepka C; Witkowski A; Konopka A; Chmielak Z; Demkow M; Debski A; Ciszewski A; Ciszewski M; Cedro K; Skwarek M; Przyłuski J; Kruk M; Kadziela J; Deptuch T; Banaszewski M; Szajewski T; Stepińska J; Ruzyłło W Kardiol Pol; 2003 May; 58(5):366-74; discussion: 374. PubMed ID: 14523484 [TBL] [Abstract][Full Text] [Related]
40. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Chen EW; Canto JG; Parsons LS; Peterson ED; Littrell KA; Every NR; Gibson CM; Hochman JS; Ohman EM; Cheeks M; Barron HV; Circulation; 2003 Aug; 108(8):951-7. PubMed ID: 12912817 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]